These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18265124)

  • 1. Generation of recombinant vaccinia viruses.
    Earl PL; Moss B; Wyatt LS; Carroll MW
    Curr Protoc Mol Biol; 2001 May; Chapter 16():Unit16.17. PubMed ID: 18265124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of recombinant vaccinia viruses.
    Earl PL; Moss B; Wyatt LS; Carroll MW
    Curr Protoc Protein Sci; 2001 May; Chapter 5():Unit5.13. PubMed ID: 18429179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of Recombinant Vaccinia Viruses.
    Wyatt LS; Earl PL; Moss B
    Curr Protoc Protein Sci; 2017 Aug; 89():5.13.1-5.13.18. PubMed ID: 28762491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Recombinant Vaccinia Viruses.
    Wyatt LS; Earl PL; Moss B
    Curr Protoc Mol Biol; 2017 Jan; 117():16.17.1-16.17.18. PubMed ID: 28060405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of Recombinant Vaccinia Viruses.
    Wyatt LS; Earl PL; Moss B
    Curr Protoc Microbiol; 2015 Nov; 39():14A.4.1-14A.4.18. PubMed ID: 26528782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Easy and efficient protocols for working with recombinant vaccinia virus MVA.
    Kremer M; Volz A; Kreijtz JH; Fux R; Lehmann MH; Sutter G
    Methods Mol Biol; 2012; 890():59-92. PubMed ID: 22688761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonreplicating vaccinia vector efficiently expresses recombinant genes.
    Sutter G; Moss B
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10847-51. PubMed ID: 1438287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methods of isolating and selecting recombinant vaccinia viruses expressing heterogenetic viral antigens].
    Gibadulin RA; Iuferov VP; Lideman LF; Parasiuk NA; Ionova KS
    Vopr Virusol; 1988; 33(4):428-31. PubMed ID: 3057744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection.
    Di Lullo G; Soprana E; Panigada M; Palini A; Erfle V; Staib C; Sutter G; Siccardi AG
    J Virol Methods; 2009 Mar; 156(1-2):37-43. PubMed ID: 19038289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use.
    Di Lullo G; Soprana E; Panigada M; Palini A; Agresti A; Comunian C; Milani A; Capua I; Erfle V; Siccardi AG
    J Virol Methods; 2010 Feb; 163(2):195-204. PubMed ID: 19778556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA)].
    Ferrer MF; Zanetti FA; Calamante G
    Rev Argent Microbiol; 2007; 39(3):138-42. PubMed ID: 17987847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early gene expression of vaccinia virus strains replicating (Praha) and non-replicating (modified vaccinia virus strain Ankara, MVA) in mammalian cells.
    Nemecková S; Hainz P; Otáhal P; Gabriel P; Sroller V; Kutinová L
    Acta Virol; 2001; 45(4):243-7. PubMed ID: 11885931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and isolation of recombinant MVA.
    Staib C; Drexler I; Sutter G
    Methods Mol Biol; 2004; 269():77-100. PubMed ID: 15114009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A novel double expression shuttle vector to get marker-free recombinant modified vaccinia virus Ankara].
    Zheng Q; Bi Z; Li M; Hou J; Chen P
    Sheng Wu Gong Cheng Xue Bao; 2011 Jun; 27(6):926-34. PubMed ID: 22034822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of recombinant vaccinia viruses and their products.
    Earl PL; Moss B
    Curr Protoc Mol Biol; 2001 May; Chapter 16():Unit16.18. PubMed ID: 18265125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of chimeric vaccinia viruses by molecular cloning and packaging.
    Scheiflinger F; Dorner F; Falkner FG
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):9977-81. PubMed ID: 1438247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of recombinant vaccinia viruses and their products.
    Earl PL; Moss B
    Curr Protoc Protein Sci; 2001 May; Chapter 5():Unit5.14. PubMed ID: 18429180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction and biological characteristic for the recombinant modified vaccinia virus ankara co-expressing modified GP5 and M protein of porcine reproductive and respiratory syndrome virus].
    Zheng Q; Li P; Cao R; Hou J; Chen P
    Sheng Wu Gong Cheng Xue Bao; 2008 May; 24(5):766-73. PubMed ID: 18724695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of Cell Cultures and Vaccinia Virus Stocks.
    Cotter CA; Earl PL; Wyatt LS; Moss B
    Curr Protoc Mol Biol; 2017 Jan; 117():16.16.1-16.16.18. PubMed ID: 28060410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and isolation of recombinant vaccinia virus using genetic markers.
    Lorenzo MM; Galindo I; Blasco R
    Methods Mol Biol; 2004; 269():15-30. PubMed ID: 15114004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.